ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TTI Thiogenesis Therapeutics Corp

0.70
0.00 (0.00%)
May 08 2024 - Closed
Delayed by 15 minutes

Thiogenesis Therapeutics Financial Summary

The current TTI market cap is 27.2M. The company's latest EPS is CAD -0.1010 and P/E is -6.93.

Year End December 30 2022 20202021202120222022
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 00000
Operating Income -31k0-1.39M-3k-3.61M
Net Income -128k-93k-1.22M-224k-3.92M
Year End December 30 2022 20202021202120222022
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 182k146k231k3.43M6.29M
Total Liabilities 6k63k1.29M3.49M307k
Total Equity 176k83k-1.06M-61k5.98M

Cash Flow

Year End December 30 2022 20202021202120222022
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -79k-36k-768k-67k-2.09M
Investing N/A N/A N/A N/A 107k
Financing 166k N/A 819k3.33M8.13M
Market Cap 27.2M
Price to Earnings Ratio -6.93
Price to Sales Ratio 0
Price to Cash Ratio 4.39
Price to Book Ratio 4.55
Dividend Yield -

Share Statistics

Shares Outstanding 38.86M
Average Volume (1 week) 22k
Average Volume (1 Month) 19.42k
52 Week Change -7.89%
52 Week High 1.06
52 Week Low 0.60
Spread (Intraday) 0.03 (4.11%)

Company Info

Company Name Thiogenesis Therapeutics Corp
Address 4 king street west, ste. 401
toronto, ontario M5H 1B6
Website https://www.thiogenesis.com
Industry unit inv tr, closed-end mgmt (6726)

Your Recent History

Delayed Upgrade Clock